Feds Allege Ranbaxy Lied About Quality of Drugs

WASHINGTON (AP) - Federal prosecutors allege that Indian generic drugmaker Ranbaxy Laboratories deliberately misled the U.S. government about the quality of its low-cost medicines.

The Justice Department is demanding Ranbaxy turn over documents which it hopes will prove the company fabricated data to convince the U.S. government to approve its products.

Read full story

Recent Posts

Do You Have Excess Skin from Weight Loss? Donate It

Can You Get Shingles from the Flu Shot?

My Itchy Journey: Overcoming 10 Years of Misdiagnosed Skin Allergies

Why Can’t I Type or Speak? Scary Symptoms that Can Accompany Migraine with Aura

Tags:

• Political Issues